We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Loss Highlights Generic Preemption Loophole
Appeals Court Loss Highlights Generic Preemption Loophole
May 11, 2012
A federal appeals court has poked a hole in generic-drug makers’ preemption protection, ruling that companies should simply stop producing a drug if it is unsafe and the warning label doesn’t reflect all concerns.